Browsing Tag
Marksans Pharma
6 posts
Ganesh Benzoplast, Quess Corp, DOMS among top losers in Indian stock market
Discover why top Indian stocks like Ganesh Benzoplast, Quess Corp, and DOMS nosedived. Full list of May 20, 2025 stock market losers and insights.
May 21, 2025
Dalal Street rocked: GRWRHITECH crashes 16.5% as top 20 stocks nosedive amid mounting global and sectoral stress
GRWRHITECH, PGIL, and GOLDIAM crash in April 4’s sharp selloff. Explore what triggered India’s top 20 stock losers and what this means for investors.
April 5, 2025
Marksans Pharma bags FDA approval for Mucinex bioequivalent tablets
Indian pharmaceutical powerhouse, Marksans Pharma has achieved a significant milestone, securing the coveted US Food and Drug Administration…
August 22, 2023
Marksans Pharma gets FDA final approval for Famotidine Tablets
Marksans Pharma said that it has been granted final approval for the over-the-counter (OTC) use of Famotidine Tablets…
March 12, 2023
Marksans Pharma secures US FDA approval for multiple strengths of Pregabalin capsules in key neuropathic pain segment
Marksans Pharma wins US FDA approval for multi-strength Pregabalin capsules, targeting a USD 263M neuropathic pain market in the United States.
July 21, 2022
Marksans Pharma’s Relonchem wins UK MHRA approval for Loperamide 2 mg capsules
Marksans Pharma’s Relonchem secures UK MHRA nod for Loperamide 2 mg capsules, boosting its UK market reach with Goa-made generics.
December 12, 2021